Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

IMW 2019 | A molecular-based approach to MM treatment

Jonathan Keats • 15 Sep 2019
IMW 2019
Chronic Myeloid Leukemia Multiple Myeloma

Jonathan Keats, PhD, Translational Genomics Research Institute, Phoenix, AZ, discusses a molecular-based approach to targeting early stages of cancer development, speaking at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

More from Jonathan Keats

Moving away from FISH and towards NGS for genetic testing in multiple myeloma
1:09
Moving away from FISH and towards NGS for genetic testing in multiple myeloma
Jonathan Keats • 8 Dec 2024
An insight into the MMRF-CoMMpass study
2:49
An insight into the MMRF-CoMMpass study
Jonathan Keats • 26 Mar 2022
Sample processing and enrichment techniques in myeloma research
3:58
Sample processing and enrichment techniques in myeloma research
Jonathan Keats • 2 Sep 2021
Proof of principle to progress treatments
1:00
Proof of principle to progress treatments
Jonathan Keats • 13 Sep 2019

Related Videos

Updated results from the iMMagine-1 trial of anito-cel in R/R multiple myeloma
4:32
Updated results from the iMMagine-1 trial of anito-cel in R/R multiple myeloma
Jonathan Keats • 18 Dec 2025
Investigating AZD0120, a dual-targeting CAR-T product, in R/R myeloma: DURGA-1 preliminary results
3:36
Investigating AZD0120, a dual-targeting CAR-T product, in R/R myeloma: DURGA-1 preliminary results
Jonathan Keats • 7 Dec 2025
A Phase II trial investigating IberKDd in R/R multiple myeloma: the ReKInDLE study
3:11
A Phase II trial investigating IberKDd in R/R multiple myeloma: the ReKInDLE study
Jonathan Keats • 7 Dec 2025
Remote therapeutic monitoring reduces infection-related hospitalizations in hematologic cancers
4:04
Remote therapeutic monitoring reduces infection-related hospitalizations in hematologic cancers
Jonathan Keats • 15 Dec 2025
The content of VJHemOnc is intended for healthcare professionals